
The offering of amniocentesis or chorionic villus sampling (CVS) for chromosome studies is recommended for pregnant women at high risk for Down syndrome. The offering of screening for Down syndrome by serum multiple-marker testing is recommended for all low-risk pregnant women, and as an alternative to amniocentesis and CVS for high-risk women.

